Glioblastoma Clinical Trials in Hangzhou, Zhejiang
3 recruitingHangzhou, Zhejiang, China
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd.42 enrolled11 locationsNCT07093814
Recruiting
Phase 1
B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma
Recurrent GlioblastomaRefractory Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University14 enrolled1 locationNCT07193628
Recruiting
Phase 2
Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
Glioblastoma (GBM)
Second Affiliated Hospital, School of Medicine, Zhejiang University38 enrolled1 locationNCT07193654